Background: The various sedative and hypnotic medications used today have the central nervous system (CNS) depressant effects. A very little work has been done on the Withania coagulans – a vulnerable species as it is not found rampant in the world except in late seventies. Therefore, it was important to explore the CNS depressant activities of aqueous extract of Withania coagulans fruits in Swiss albino mice by using rota rod test.
Methods: Motor coordination was assessed by using the Rota Rod Test. The CNS depressant drugs decrease the endurance time of mice on the rota rod as they impair the motor coordination so that mice fall early on the rotating rod. This endurance time is statistically correlated among the control, standard and the test drugs.
Results: There was statistically highly significant (p-value < 0.001) association observed between aqueous extract of Withania coagulans fruits with endurance time in Swiss albino mice on rota rod test.
Conclusion: The aqueous extract of Withania coagulans fruits demonstrated the CNS depressant activity in Swiss albino mice by rota rod test.
A. S. D. Association, (1997) “International classification of sleep disorders. Revised: Diagnostic and coding manual,”, Academy of Sleep Medicine. [Online]. Available: http://www.absm.Org/PDF/ICSD.Pdf.
D. J. Buysse, J. Angst, A. Gamma, V. Ajdacic, D. Eich, and W. Rössler, “Prevalence, course, and comorbidity of insomnia and depression in young adults,” Sleep, vol. 31, no. 4, pp. 473–480, 2008.
S. Schutte-Rodin, L. Broch, D. Buysse, C. Dorsey, and M. Sateia, “Clinical guideline for the evaluation and management of chronic insomnia in adults”, J. Clin. Sleep Med., vol. 4, no. 5, pp. 487–504, 2008.
D. J. Taylor, L. J. Mallory, K. L. Lichstein, H. H. Durrence, B. W. Riedel, and A. J. Bush, “Comorbidity of chronic insomnia with medical problems”, Sleep, vol. 30, no. 2, pp. 213–218, 2007.
S. Panda, A. B. Taly, S. Sinha, G. Gururaj, N. Girish, and D. Nagaraja, “Sleep-related disorders among a healthy population in South India”, Neurol. India, vol. 60, no. 1, p. 68, 2012.
H. Shiotsuki et al., “A rotarod test for evaluation of motor skill learning”, J. Neurosci. Methods, vol. 189, no. 2, pp. 180–185, 2010.
N. W. Dunham and T. S. Miya, “A note on a simple apparatus for detecting neurological deficit in rats and mice”, J. Am. Pharm. Assoc., vol. 46, no. 3, pp. 208–209, 1957.
W. J. Kinnard Jr and C. J. Carr, “A preliminary procedure for the evaluation of central nervous system depressants”, J. Pharmacol. Exp. Ther., vol. 121, no. 3, pp. 354–361, 1957.
M. I. Gluckman, “Pharmacology of oxazepam (Serax), a new anti-anxiety agent”, Curr. Ther. Res. Clin. Exp., vol. 7, no. 11, p. 721, 1965.
N. Plotnikoff, D. Reinke, and J. Fitzloff, “Effects of stimulants on rotarod performance of mice”, J. Pharm. Sci., vol. 51, no. 10, pp. 1007–1008, 1962.
I. Pandey and K. S. Nama, “Withania Coagulans (Stocks) Dunal – A Rare Ethnomedicinal Plant of the Western Rajasthan Desert”, Int. J. Phar. & Biomedi. Rese, vol. 2, no. 2, pp. 34–40, 2015.
S. B. Meeran, U. Subburaya, and G. Narasimhan, “In Silico and In Vitro Screening of Ethanolic Extract of Fruits of Withania Coagulans against Diabetes”, Res. J. Pharm. Technol., vol. 13, no. 2, pp. 631–635, 2020.
S. Ojha et al., “Withania coagulans fruit extract reduces oxidative stress and inflammation in kidneys of streptozotocin-induced diabetic rats”, Oxid. Med. Cell. Longev., vol. 2014, no. October 2015, 2014.
S. Hemalatha, A. K. Wahi, P. N. Singh, and J. P. N. Chansouria, “Hypoglycemic activity of Withania coagulans Dunal in streptozotocin induced diabetic rats”, J. Ethnopharmacol., vol. 93, no. 2–3, pp. 261–4, Aug. 2004.
R. D. Budhiraja, S. Bala, and K. N. Garg, “Pharmacological investigations on fruits of Withania coagulans, Dunal”, Planta Med., vol. 32, no. 2, pp. 154–7, Sep. 1977.
J. F. Cryan et al., “Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N, N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines”, J. Pharmacol. Exp. Ther., vol. 310, no. 3, pp. 952–963, 2004.
A. Sood, A. Kumar, D. K. Dhawan, and R. Sandhir, “Propensity of Withania somnifera to Attenuate Behavioural, Biochemical, and Histological Alterations in Experimental Model of Stroke”, Cell. Mol. Neurobiol., pp. 1–16, 2015.
R. J. Carter, J. Morton, and S. B. Dunnett, “Motor coordination and balance in rodents”, Curr. Protoc. Neurosis., pp. 8–12, 2001.
N. Watzman, H. Barry 3rd, W. J. Kinnard Jr, and J. P. Buckley, “Influence of certain parameters on the performance of mice on the rotarod”, Arch. Int. Pharmacodyn. thérapie, vol. 169, no. 2, p. 362, 1967.
B. J. Jones and D. J. Roberts, “The quantitative measurement of motor inco‐ordination in naive mice using an accelerating rotarod”, J. Pharm. Pharmacol., vol. 20, no. 4, pp. 302–304, 1968.
H. Kuribara, Y. Higuchi, and S. Tadokoro, “Effects of central depressants on rota-rod and traction performances in mice”, Jpn. J. Pharmacol., vol. 27, no. 1, pp. 117–126, 1977.
This work is licensed under a Creative Commons Attribution 4.0 International License.